Investors
-
Regulatory May 8, 2025Report from Annual General Meeting in Vivesto AB
-
Regulatory April 8, 2025Notice of Annual General Meeting in Vivesto AB
-
Non Regulatory April 1, 2025Vivesto reports positive Cantrixil results in an animal hematological cancer model
Vivesto published its Q1 report for 2025 on May 8, 2025, at 08.00 am CEST.